Table 3.
Effect of pregnancy on immunosuppression
| Tacrolimus dosea (mg/day) | Tacrolimus levelb (ng/ml) | |
|---|---|---|
| Before | ||
| Mean | 10.3 | 0.7 |
| SD | 3.3 | 0.3 |
| Median | 11 | 0.6 |
| First Trimester | ||
| Mean | 9.7 | 0.7 |
| SD | 3.3 | 0.3 |
| Median | 10 | 0.7 |
| Second Trimester | ||
| Mean | 9.3 | 0.7 |
| SD | 3.6 | 0.5 |
| Median | 10 | 0.5 |
| Third Trimester | ||
| Mean | 10.1 | 0.5 |
| SD | 3.9 | 0.3 |
| Median | 10 | 0.45 |
| Postpartum | ||
| Mean | 9.8 | 0.8 |
| SD | 4 | 0.4 |
| Median | 10 | 0.65 |
Excludes patient 6 with colitis, receiving 48–64 mg/day.
Plasma level.